AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.

Bibliographische Detailangaben
Hauptverfasser:	Ana Isabel Rodríguez Pérez, María A Pedrosa, Carmen M Labandeira, Rita Valenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan Antonio Suárez-Quintanilla, Jose Lanciego, José Luis Labandeira-García
Format:	Artikel
Sprache:	English
Veröffentlicht:	Elsevier 2023-10-01
Schriftenreihe:	IBRO Neuroscience Reports
Online Zugang:	http://www.sciencedirect.com/science/article/pii/S2667242123010126

Online